6 research outputs found
Pharmacological and clinical profile of a new SGLT2 inhibitor, luseogliflozin (Lusefi<sup>®</sup>)
No full text
In vitro characterization of luseogliflozin, a potent and competitive sodium glucose co-transporter 2 inhibitor: Inhibition kinetics and binding studies
No full textTP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics-pharmacodynamics correlation
No full text
